Further investigation has shown that FBP1 acts as a metabolic tumor suppressor by inhibiting proliferation, migration, and invasion, resulting in a decrease in aerobic glycolysis and sensitizing cancer cells to chemotherapy‐induced apoptosis. This evidence concerns the gene FBP1 and cancer.